Position in ARDX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,931,639
-$312,808 QoQ
Shares Held
770,910
+8.8% QoQ
Ownership
0.309%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 250 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. ARDX ranks #72 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in ARDX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,931,639 | 770,910 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $4,244,447 | 708,589 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $2,916,136 | 500,195 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,068,917 | 193,996 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $668,617 | 170,566 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,511,764 | 307,895 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,662,452 | 327,900 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $1,802,747 | 261,647 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $10,756,458 | 1,451,614 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $9,744,841 | 1,334,910 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $7,025,510 | 1,133,147 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,695,031 | 1,150,743 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $3,831,726 | 1,130,303 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,315,330 | 900,904 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,308,796 | 810,104 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $964,023 | 810,104 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $477,961 | 810,104 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $921,131 | 860,871 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,064,201 | 967,457 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $1,144,659 | 867,167 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $6,606,378 | 871,554 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,699,870 | 558,893 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,715,823 | 574,316 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,364,799 | 450,438 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,872,989 | 415,172 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $744,740 | 131,001 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||